<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37789876</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Two-year trajectories of COVID-19 symptoms and their association with illness perception: A prospective cohort study in Amsterdam, the Netherlands.</ArticleTitle><Pagination><StartPage>e13190</StartPage><MedlinePgn>e13190</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13190</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.13190</ELocationID><Abstract><AbstractText Label="BACKGROUND">We used data from a prospective cohort to explore 2-year trajectories of 'long COVID' (persistent symptoms after SARS-CoV-2 infection) and their association with illness perception.</AbstractText><AbstractText Label="METHODS">RECoVERED participants (adults; prospectively enrolled following laboratory-confirmed SARS-CoV-2 infection, May 2020-June 2021) completed symptom questionnaires at months 2-12, 18 and 24, and the Brief Illness Perception Questionnaire (B-IPQ) at months 1, 6 and 12. Using group-based trajectory models (GBTM), we modelled symptoms (mean total numbers and proportion with four specific complaints), including age, sex, BMI and timing of infection as covariates. In a multivariable linear mixed-effects model, we assessed the association between symptom trajectories and repeated B-IPQ scores.</AbstractText><AbstractText Label="RESULTS">Among 292 participants (42% female; median age 51 [IQR&#x2009;=&#x2009;36-62]), four trajectories were identified, ranging from Trajectory 4 (8.9%; 6&#x2009;+&#x2009;symptoms) to Trajectory 1 (24.8%; no symptoms). The occurrence of fatigue and myalgia increased among 23% and 12% of participants, respectively. Individuals in Trajectory 4 experienced more negative adjusted B-IPQ scores over time than those in Trajectories 1-3.</AbstractText><AbstractText Label="CONCLUSIONS">We observed little fluctuation in the total number of symptoms, but individual symptoms may develop as others resolve. Reporting a greater number of symptoms was congruent with more negative illness perception over time.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wynberg</LastName><ForeName>Elke</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8245-086X</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology &amp; Infection Prevention, Amsterdam UMC University of Amsterdam, Amsterdam Institute for Infection and Immunity Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verveen</LastName><ForeName>Anouk</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Psychology, Amsterdam UMC, Amsterdam Public Health Research Institute University of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Willigen</LastName><ForeName>Hugo D G</ForeName><Initials>HDG</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology &amp; Infection Prevention, Amsterdam UMC University of Amsterdam, Amsterdam Institute for Infection and Immunity Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieuwkerk</LastName><ForeName>Pythia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Psychology, Amsterdam UMC, Amsterdam Public Health Research Institute University of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davidovich</LastName><ForeName>Udi</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Psychology, Amsterdam UMC, Amsterdam Public Health Research Institute University of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lok</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Amsterdam UMC University of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Jong</LastName><ForeName>Menno D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology &amp; Infection Prevention, Amsterdam UMC University of Amsterdam, Amsterdam Institute for Infection and Immunity Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Bree</LastName><ForeName>Godelieve J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Amsterdam UMC, University of Amsterdam Amsterdam Institute for Infection and Immunity Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leenstra</LastName><ForeName>Tjalling</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Infectious Disease Control (LCI) National Institute for Public Health and the Environment (RIVM) Bilthoven Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knoop</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Psychology, Amsterdam UMC, Amsterdam Public Health Research Institute University of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prins</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Amsterdam UMC, University of Amsterdam Amsterdam Institute for Infection and Immunity Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyd</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stichting HIV Monitoring Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>RECoVERED Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010465" MajorTopicYN="N">Perception</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">illness perception</Keyword><Keyword MajorTopicYN="N">sequelae</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword><Keyword MajorTopicYN="N">trajectories</Keyword></KeywordList><CoiStatement>The authors have no relevant conflicts of interests to declare.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Agard</LastName><ForeName>Ivette</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ayal</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cavdar</LastName><ForeName>Floor</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Craanen</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Deuring</LastName><ForeName>Annemarieke</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Annelies</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dijkstra</LastName><ForeName>Maartje</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ersan</LastName><ForeName>Ertan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Del Grande</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hartman</LastName><ForeName>Joost</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koedoot</LastName><ForeName>Nelleke</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lebbink</LastName><ForeName>Romy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Loomans</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Makowska</LastName><ForeName>Agata</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>du Maine</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>de Man</LastName><ForeName>Ilja</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Matser</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van der Meij</LastName><ForeName>Lizenka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van Polanen</LastName><ForeName>Marleen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oud</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Reid</LastName><ForeName>Clark</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Storey</LastName><ForeName>Leeann</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van Wijk</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Public Health Service of Amsterdam Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van den Aardweg</LastName><ForeName>Joost</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van Assem</LastName><ForeName>Joyce</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van Beek</LastName><ForeName>Marijne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Figaroa</LastName><ForeName>Orlane</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Frenkel</LastName><ForeName>Leah</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van Gils</LastName><ForeName>Marit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Han</LastName><ForeName>Xiaochuan Alvin</ForeName><Initials>XA</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Harskamp-Holwerda</LastName><ForeName>Agnes</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hazenberg</LastName><ForeName>Mette</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hidad</LastName><ForeName>Soemeja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>de Jong</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kootstra</LastName><ForeName>Neeltje</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kuijt</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moll van Charante</LastName><ForeName>Eric P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Russell</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van der Straten</LastName><ForeName>Karlijn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van der Veen</LastName><ForeName>Annelou</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Verkaik</LastName><ForeName>Bas</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Visser</LastName><ForeName>Gerben-Rienk</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Amsterdam University Medical Centres Amsterdam the Netherlands.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>3</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37789876</ArticleId><ArticleId IdType="pmc">PMC10542619</ArticleId><ArticleId IdType="doi">10.1111/irv.13190</ArticleId><ArticleId IdType="pii">IRV13190</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO . WHO coronavirus (COVID&#x2010;19) dashboard. World Health Organization; 2022.</Citation></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID&#x2010;19: A Systematic Review. (2574&#x2010;3805 [Electronic]).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SK, Olde Hartman TC, Rosmalen JG. Persistence of somatic symptoms after COVID&#x2010;19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2010;461. doi:10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . A clinical case definition of post COVID&#x2010;19 condition by a Delphi consensus. World Health Organization (WHO) clinical case definition working group on post COVID&#x2010;19 condition. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. Persistent symptoms after Covid&#x2010;19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1):1144. doi:10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Ireson J, Taylor A, Richardson E, Greenfield B, Jones G. Exploring invisibility and epistemic injustice in long Covid&#x2014;a citizen science qualitative analysis of patient stories from an online Covid community. Health Expect. 2022;25(4):1753&#x2010;1765. doi:10.1111/hex.13518</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hex.13518</ArticleId><ArticleId IdType="pmc">PMC9327841</ArticleId><ArticleId IdType="pubmed">35557480</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilcot J, Wellsted D, Fau&#x2010;Farrington K, Farrington K. Illness perceptions predict survival in haemodialysis patients. (1421&#x2010;9670 [Electronic]).</Citation><ArticleIdList><ArticleId IdType="pubmed">21430374</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Hong L, Zhang T, et al. Illness perceptions and stress: mediators between disease severity and psychological well&#x2010;being and quality of life among patients with Crohn's disease. (1177&#x2010;889X [Print]).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5125764</ArticleId><ArticleId IdType="pubmed">27920505</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E, van Willigen HDG, Dijkstra M, et al. Evolution of coronavirus disease 2019 (COVID&#x2010;19) symptoms during the first 12 months after illness onset. Clin Infect Dis. 2022;75(1):e482&#x2010;e490. doi:10.1093/cid/ciab759</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab759</ArticleId><ArticleId IdType="pmc">PMC8522402</ArticleId><ArticleId IdType="pubmed">34473245</ArticleId></ArticleIdList></Reference><Reference><Citation>
ISARIC
. Clinical Data Collection &#x2013; The COVID&#x2010;19 Case Report Forms (CRFs). Accessed 18 February. Available at: https://isaric.org/research/covid-19-clinical-research-resources/covid-19-crf/
</Citation></Reference><Reference><Citation>Basu S, Fau&#x2010;Poole J, Poole J. The Brief Illness Perception Questionnaire. (1471&#x2010;8405 [Electronic]).</Citation></Reference><Reference><Citation>
Weinman J. Brief Illness Perception Questionnaire/Illness Perception Questionnaire&#x2010;Kort/Ziekteperceptievragenlijst. Accessed 29 November. Available at: https://meetinstrumentenzorg.nl/instrumenten/brief-illness-perception-questionnaire-illness-perception-questionnaire-kort-ziekteperceptievragenlijst/
</Citation></Reference><Reference><Citation>Coyer L, Wynberg E, Buster M, et al. Hospitalisation rates differed by city district and ethnicity during the first wave of COVID&#x2010;19 in Amsterdam, the Netherlands. medRxiv 2021: 2021.03.15.21253597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456400</ArticleId><ArticleId IdType="pubmed">34551752</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh CA&#x2010;O, Mucherino S, Orlando V, Bennett KE, Menditto E, Cahir C. Mapping the use of Group&#x2010;Based Trajectory Modelling in medication adherence research: A scoping review protocol. (2515&#x2010;4826 [Electronic]).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265572</ArticleId><ArticleId IdType="pubmed">32551416</ArticleId></ArticleIdList></Reference><Reference><Citation>
RIVM
. Varianten van het coronavirus SARS&#x2010;CoV&#x2010;2. Accessed 1 April 2023. Available at: https://www.rivm.nl/coronavirus-covid-19/virus/varianten
</Citation></Reference><Reference><Citation>Evans RA, Leavy OC, Richardson M, et al. Clinical characteristics with inflammation profiling of long COVID and association with 1&#x2010;year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761&#x2010;775. doi:10.1016/S2213-2600(22)00127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Torres&#x2010;Macho J, Velasco&#x2010;Arribas M, et al. Preexisting hypertension is associated with a greater number of long&#x2010;term post&#x2010;COVID symptoms and poor sleep quality: a case&#x2013;control study. J Hum Hypertens. 2022;36(6):1&#x2010;3. doi:10.1038/s41371-022-00660-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-022-00660-6</ArticleId><ArticleId IdType="pmc">PMC8853057</ArticleId><ArticleId IdType="pubmed">35173268</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G, Diodati F, Puntoni M, et al. Prognostic factors for post&#x2010;COVID&#x2010;19 syndrome: a systematic review and meta&#x2010;analysis. J Clin Med. 2022;11(6):1541. doi:10.3390/jcm11061541</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Mart&#xed;n&#x2010;Guerrero JD, Pellicer&#x2010;Valero &#xd3;J, et al. Female sex is a risk factor associated with long&#x2010;term post&#x2010;COVID related&#x2010;symptoms but not with COVID&#x2010;19 symptoms: the LONG&#x2010;COVID&#x2010;EXP&#x2010;CM multicenter study. J Clin Med. 2022;11(2):413. doi:10.3390/jcm11020413</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V&#x2010;T, Porcher R, Pane I, Ravaud P. Course of post COVID&#x2010;19 disease symptoms over time in the ComPaRe long COVID prospective e&#x2010;cohort. Nat Commun. 2022;13(1):1812. doi:10.1038/s41467-022-29513-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;fner K, Tymoszuk P, Sahanic S, et al. Persistent somatic symptoms are key to individual illness perception at one year after COVID&#x2010;19 in a cross&#x2010;sectional analysis of a prospective cohort study. (1879&#x2010;1360 [Electronic]).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10022460</ArticleId><ArticleId IdType="pubmed">36965396</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens MBS. Zo kom je zonder angst en stress de tweede golf door. NOS 2020 18 October 2020.</Citation></Reference><Reference><Citation>de Sim&#xe9;on B, van Albert Jan H, Elizabeth NM, et al. Lower prevalence of Post&#x2010;Covid&#x2010;19 Condition following Omicron SARS&#x2010;CoV&#x2010;2 infection. medRxiv; 2023: 2023.04.05.23288157.</Citation></Reference><Reference><Citation>Wynberg E, Han AX, Boyd A, et al. The effect of SARS&#x2010;CoV&#x2010;2 vaccination on post&#x2010;acute sequelae of COVID&#x2010;19 (PASC): A prospective cohort study. (1873&#x2010;2518 [Electronic]).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>